Company
Perceptive Advisors
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Superluminal Medicines | Series B | 2026-09-03 | |
| Imperative Care, Inc. | Convertible Note | 2026-03-18 | Lead |
| Talkiatry | Series D | 2026-02-12 | Lead |
| Affinia Therapeutics | Series C | 2025-10-08 | |
| Caris Life Sciences | Growth Funding | 2025-04-07 | |
| Kardigan | Series A | 2025-01-13 | Lead |
| Axonis Therapeutics | Series A Funding | 2024-10-30 | |
| Talkiatry | Series C Funding | 2024-06-18 | |
| CinDome Pharma | series b extension | 2024-05-16 | |
| Endeavor BioMedicines, Inc | Series C Funding | 2024-04-24 | |
| TORL BioTherapeutics | Series B-2 Funding | 2024-04-10 | |
| Capstan Therapeutics | Series B Financing | 2024-03-21 | |
| Freenome | Funding | 2024-02-15 | |
| Rapport Therapeutics | Series B Funding | 2023-08-23 | Lead |
| AsclepiX Therapeutics | Series A-3 Funding | 2023-07-26 | Lead |